CFA
ABBV icon

Cahill Financial Advisors’s AbbVie ABBV Stock Holding History

Cahill Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$585K Sell
2,691
-18
-0.7% -$3.99K 0.06% 163
2025
Q4 		$619K Sell
2,709
-337
-11% -$76.8K 0.07% 154
2025
Q3 		$705K Buy
3,046
+231
+8% +$47K 0.08% 150
2025
Q2 		$523K Sell
2,815
-164
-6% -$30.5K 0.06% 165
2025
Q1 		$624K Buy
2,979
+160
+6% +$31.1K 0.08% 145
2024
Q4 		$501K Buy
+2,819
New +$518K 0.07% 163
2021
Q4 		– Sell
-113
Closed -$12K – 219
2021
Q3 		$12K Buy
+113
New +$12.9K ﹤0.01% 516

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cahill Financial Advisors's ABBV Position: Q1 2026 in Review

Cahill Financial Advisors reduced its AbbVie (ABBV) stake by 0.66% in Q1 2026, selling an estimated $3.99K and leaving 2,691 shares worth $585K. The position accounts for 0.06% of the portfolio, ranked #163.

Cahill Financial Advisors first reported a position in ABBV in Q3 2021 and has held it in 7 quarters since. The position peaked at $705K in Q3 2025. 4,081 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Cahill Financial Advisors held 2,691 shares of AbbVie worth $585K as of Q1 2026.
  • Cahill Financial Advisors sold 18 AbbVie shares in Q1 2026, an estimated $3.99K.
  • AbbVie made up 0.06% of Cahill Financial Advisors's portfolio in Q1 2026, its #163 holding.
  • Cahill Financial Advisors first reported a position in AbbVie in Q3 2021 and has held it in 7 quarters since.
  • Cahill Financial Advisors's AbbVie position peaked at $705K in Q3 2025.
  • 4,081 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Cahill Financial Advisors's 13F filing for Q1 2026, filed 13 May 2026.